extrem
potent
botulinum
neurotoxin
bont
produc
strictli
anaerob
gramposit
bacterium
clostridium
botulinum
c
botulinum
like
candid
use
seven
serotyp
c
botulinum
produc
immunolog
distinguish
neurotoxin
variant
type
human
botul
mainli
involv
type
b
e
bont
deadli
natur
toxic
substanc
heavi
chain
bont
compos
ntermin
transloc
domain
ctermin
receptorbind
ctermin
end
heavi
chain
respons
specif
toxin
bind
neuromuscular
numer
previou
studi
prove
subunit
bont
nontox
antigen
capabl
elicit
immun
respons
licens
vaccin
protect
botul
although
pentaval
botulinum
toxoid
pbt
investig
new
drug
ind
vaccin
type
e
vaccin
mixtur
chemic
inactiv
bont
produc
c
botulinum
concern
rais
regard
safeti
process
produc
toxin
creat
limit
produc
time
elimin
risk
difficulti
associ
produc
toxinbas
vaccin
altern
vaccin
botul
sought
date
progress
occur
recombin
subunit
replicationincompet
adenovirus
express
vaccin
antigen
effect
deliv
either
parenter
mucos
rout
transgen
express
adenoviru
vector
usual
robust
enhanc
drive
gene
express
strong
heterolog
promot
vector
genom
insert
host
chromosom
ensur
safe
deliveri
addit
adenovirus
grown
high
titer
qualifi
cell
advantag
make
adenovirus
attract
vaccin
vector
use
wide
develop
vaccin
hiv
sar
sever
acut
respiratori
syndrom
avian
influenza
tuberculosi
previou
studi
construct
replicationincompet
adenovir
vector
contain
synthes
condonoptim
gene
encod
bont
type
c
evalu
vaccin
potenti
intramuscular
im
studi
use
adenovirusbas
vaccin
deliv
intranas
mucos
rout
show
longlast
protect
immun
occur
singl
dose
immun
respons
sera
singl
vaccin
vari
dose
adenovir
vector
shown
figur
preimmun
sera
week
sera
mice
vaccin
neg
control
vector
adnul
adenoviru
vector
without
transgen
data
shown
neg
igg
respons
detect
week
three
dose
evalu
even
lowest
dose
pfu
plaqueform
unit
serum
igg
level
significantli
higher
control
mice
receiv
adnul
p
time
cours
respons
serum
igg
vaccin
mice
also
shown
figur
overal
dose
rang
studi
show
serum
igg
concentr
mice
receiv
pfu
highest
mice
receiv
pfumous
achiev
serum
igg
concentr
respect
week
week
week
serum
igg
antibodi
continu
increas
time
week
vaccin
figur
respons
mice
week
vaccin
account
threefourth
total
igg
concentr
sera
vaccin
mice
significantli
increas
week
compar
week
antibodi
also
produc
vaccin
although
lower
magnitud
figur
separ
experi
assess
antibodi
persist
singl
dose
pfumous
adenovir
vector
vaccin
figur
measur
made
week
post
vaccin
igg
found
antibodi
level
persist
level
similar
post
week
vaccin
significantli
declin
week
show
predomin
observ
post
week
evalu
mucos
immun
respons
analyz
specif
igg
iga
antibodi
concentr
saliva
nasal
wash
vagin
wash
sampl
vaccin
adenovir
vector
vaccin
singl
vaccin
pfumous
result
signific
igg
iga
antibodi
respons
figur
week
vaccin
high
local
antibodi
respons
measur
wherea
specif
antibodi
detect
sampl
control
mice
examin
antibodi
level
saliva
nasal
wash
vagin
wash
sampl
vaccin
mice
week
significantli
higher
week
igg
antibodi
concentr
mucos
sampl
lower
sera
p
ratio
revers
compar
serum
p
mucos
iga
saliva
reach
ng
week
ng
week
wherea
sera
iga
data
shown
detect
neutral
capac
antisera
mice
vaccin
adenovir
vector
vaccin
determin
use
mous
bioassay
owe
limit
amount
serum
avail
sera
eight
vaccin
mice
pool
result
shown
figur
neutral
titer
mice
receiv
singl
dose
pfumous
iu
week
vaccin
antiserum
mice
dilut
complet
neutral
mous
lethal
dose
bontc
result
surviv
serum
control
mice
neutral
neurotoxin
singl
dose
vaccin
adenovir
vector
mice
challeng
intraperiton
ip
activ
bontc
result
summar
figur
week
singl
vaccin
none
mice
receiv
control
vector
adnul
surviv
toxin
challeng
wherea
mice
receiv
pfu
mice
receiv
pfumous
surviv
challeng
botul
symptom
figur
overal
mice
lowest
vaccin
dose
studi
pfu
die
one
four
surviv
mice
show
botul
symptom
contrast
mice
receiv
one
dose
botulinum
toxoid
adsorb
pentaval
vaccin
abcd
surviv
challeng
figur
addit
shown
figur
week
immun
mice
given
pfu
also
complet
protect
bontc
toxin
show
vaccin
potenc
protect
higher
dose
activ
bontc
also
use
toxin
challeng
figur
show
anim
vaccin
pfu
could
complet
protect
challeng
bontc
week
vaccin
howev
protect
rate
decreas
mice
bontc
toxin
challeng
dose
increas
show
protect
immun
also
toxin
challeng
dose
depend
determin
impact
preexist
antihuman
neutral
antibodi
efficaci
vaccin
mice
preinocul
pfu
wildtyp
week
receiv
vaccin
signific
serum
neutral
antibodi
titer
produc
figur
anim
preexist
immun
given
singl
dose
pfu
week
vaccin
anim
ip
challeng
bontc
vaccin
anim
fulli
protect
bontc
challeng
figur
contrast
none
control
mice
surviv
toxin
challeng
figur
addit
vitro
toxin
neutral
assay
found
singl
dose
vaccin
elicit
titer
antitoxin
antibodi
respons
titer
iu
regardless
host
preexist
immun
adenovir
vector
figur
data
suggest
vector
could
provid
protect
bontc
neurotoxin
preexist
immun
adenoviru
host
neurotoxin
produc
c
botulinum
among
potent
poison
known
need
prepar
use
bioterror
natur
human
botul
mainli
involv
bont
type
b
e
serotyp
c
mostli
affect
domest
anim
given
eas
prepar
potenti
toxic
neurotoxin
equal
import
develop
vaccin
toxin
biodefens
studi
evalu
vaccin
strategi
bontc
expect
ultim
appli
platform
develop
vaccin
serotyp
bont
describ
novel
adenovir
vector
deliveri
botul
vaccin
type
c
neurotoxin
deliv
singl
dose
prove
highli
effect
vaccin
owe
singl
rout
vaccin
vaccin
could
selfadminist
protect
popul
event
terrorist
attack
c
botul
neurotoxin
addit
eas
administr
rapid
onset
protect
describ
vaccin
could
produc
inexpens
high
quantiti
short
time
frame
chose
fragment
bont
type
c
subunit
bont
nontox
antigen
capabl
elicit
immun
respons
also
previou
studi
show
im
vaccin
elicit
strong
system
immun
last
least
week
mice
receiv
vaccin
fulli
protect
bontc
bont
lethal
ingest
minut
amount
food
andor
inhal
latter
deliveri
mode
strongest
bioterrorismrel
mucos
immun
system
first
line
defens
botul
howev
current
injectiontyp
botul
toxoid
vaccin
provid
protect
immun
system
compart
clearli
develop
safe
effect
mucos
vaccin
high
prioriti
bioterrorismrel
previou
research
kobayashi
et
show
nasal
vaccin
bonta
toxoid
plu
mutant
cholera
toxin
effect
prevent
mucos
bont
intox
mice
maddaloni
et
recent
show
mucos
vaccin
adenoviru
type
fiber
fuse
bonta
elicit
robust
mucos
antibodi
respons
addit
cholera
toxin
ct
adjuvunt
vaccin
enhanc
protect
immun
mice
challeng
activ
bonta
studi
prove
feasibl
develop
nasal
vaccin
botul
adenovirus
invad
host
natur
mucosa
surfac
notabl
respiratori
gastrointestin
adenovir
vector
vaccin
effect
deliv
mucos
rout
induc
strong
adapt
immun
respons
mammalian
replicationincompet
adenovir
vector
studi
given
protect
singl
vaccin
elicit
high
serum
antibodi
respons
also
high
specif
antibodi
respons
mucos
secret
protect
botul
neurotoxin
expect
antibodymedi
antibodi
level
correl
mice
receiv
develop
high
persist
serum
neutral
titer
high
mucos
antibodi
level
function
antibodi
respons
neutral
activ
bont
shown
experi
protect
bontc
vaccin
anim
shown
persist
least
week
futur
studi
plan
determin
whether
toxinspecif
mucos
antibodi
protect
measur
toxin
neutral
antibodi
titer
mucos
secret
mucos
immun
perform
toxin
challeng
nasal
mucos
rout
addit
ip
rout
studi
establish
preexist
antiadenoviru
antibodi
may
drastic
reduc
intak
adenovirusvector
immun
vector
overcom
challeng
experi
indic
preexist
antiadenoviru
immun
reduc
protect
vaccin
mice
similar
previou
result
im
make
observ
convinc
similar
experi
higher
dose
toxin
challeng
lower
dose
vaccin
mice
preexist
immun
adenoviru
would
help
summari
studi
shown
first
time
singl
vaccin
adenovirusbas
vector
encod
human
hc
bontc
elicit
system
mucosa
immun
respons
provid
full
protect
vaccin
mice
bont
type
c
protect
immun
last
least
week
compromis
preexist
antibodi
adenoviru
togeth
previou
result
im
vaccin
adenovirus
vector
platform
deserv
studi
multival
vaccin
serotyp
bont
replicationincompet
human
adenoviru
serotyp
vector
express
bontc
control
vector
adnul
adenoviru
vector
transgen
construct
use
adeasi
system
stratagen
la
jolla
ca
usa
describ
vector
contain
synthes
human
codonoptim
gene
encod
bont
type
nativ
gene
encod
signal
peptid
human
tissu
plasminogen
activ
plat
amino
acid
genbank
access
recombin
adenovirus
produc
cell
stratagen
purifi
cscl
gradient
centrifug
store
sucros
freezer
titer
pfu
determin
plaqu
assay
evalu
optim
dose
mice
allot
experiment
group
two
control
group
mice
per
group
anim
vaccin
inhal
adenovir
vector
dose
pfumous
respect
experiment
group
adnul
dose
pfumous
neg
control
group
posit
control
group
mice
inject
im
botulinum
toxoid
adsorb
pentaval
vaccin
abcd
ind
vaccin
produc
michigan
depart
public
health
serum
sampl
obtain
week
store
assay
vaccin
mice
ip
challeng
bont
week
last
bleed
describ
follow
section
experi
mice
divid
test
group
control
group
mice
per
group
anim
vaccin
pfumous
test
group
amount
adnul
control
group
week
saliva
nasal
wash
vagin
wash
sampl
collect
week
one
test
group
one
control
group
week
one
test
group
one
control
group
time
point
mice
anesthet
ip
inject
mg
ketamin
hcl
bedford
laboratori
bedford
oh
usa
plu
mg
xylazin
butler
compani
columbu
oh
usa
vagin
wash
collect
flush
vagina
phosphatebuff
salin
pb
repeat
aspir
use
pipett
anim
feed
needl
ball
head
saliva
sampl
collect
use
pipett
fit
plastic
tip
ip
inject
carbachol
sigma
chemic
co
st
loui
mo
usa
ml
stimul
saliv
describ
mice
incis
ventral
along
median
line
xiphoid
process
chin
head
remov
lower
jaw
excis
hypoderm
needl
insert
posterior
open
nasopharynx
pb
inject
repeatedli
collect
nasal
wash
vaccin
control
mice
ip
challeng
c
botulinum
neurotoxin
bontc
metabiolg
inc
madison
wi
usa
per
mous
specifi
experi
challeng
anim
monitor
everi
h
first
day
twice
day
thereaft
total
day
number
death
group
record
end
experi
mice
allot
test
group
control
group
mice
per
group
anim
vaccin
week
vector
dose
pfumous
test
group
adnul
dosag
control
group
one
test
group
one
control
group
mice
challeng
bontc
week
respect
serum
sampl
obtain
week
week
challeng
total
mice
allot
one
experiment
group
mice
one
control
group
mice
anim
inocul
widetyp
human
adenoviru
serotyp
wt
atcc
manassa
va
usa
dose
pfumous
vaccin
nasal
inhal
week
vector
dose
pfumous
experiment
group
adnul
dose
control
group
serum
sampl
obtain
week
inocul
wt
vaccin
respect
vaccin
anim
subsequ
challeng
bontc
week
elisa
quantit
kit
bethel
lab
inc
montgomeri
tx
usa
use
measur
igg
iga
concentr
serum
saliva
nasal
wash
vagin
wash
sampl
describ
briefli
plate
coat
overnight
recombin
protein
coat
buffer
buffer
ph
rins
wash
buffer
tween
pb
five
time
nonspecif
bind
site
block
block
buffer
bovin
serum
albumin
bsa
pb
ph
h
room
temperatur
follow
wash
five
time
later
dilut
sera
pb
ph
tween
bsa
ad
well
incub
h
five
wash
plate
incub
h
room
temperatur
dilut
goat
antimous
igg
conjug
alkalin
phosphat
color
reaction
develop
incub
pnitrophenylphosph
phosphatas
substrat
system
kpl
gaithersburg
md
usa
min
room
temperatur
absorb
valu
obtain
use
dynatech
micropl
reader
standard
curv
antibodi
quantit
compani
sourc
gener
parallel
allow
antibodi
concentr
neutral
titer
mice
sera
bontc
determin
describ
briefli
sera
eight
mice
week
vaccin
pfumous
pool
dilut
twofold
seri
pb
activ
bontc
ad
dilut
follow
incub
room
temperatur
h
mous
inject
ip
mixtur
antiserum
bontc
correspond
bontc
neutral
four
mice
dilut
anim
monitor
day
number
death
sampl
dilut
record
anim
surviv
bontc
toxin
neutral
neutral
antibodi
titer
defin
maximum
number
iu
antitoxin
per
ml
serum
result
surviv
challeng
one
iu
type
c
antitoxin
neutral
antiadenoviru
neutral
antibodi
titer
evalu
use
modif
previous
describ
briefli
cell
stratagen
seed
plate
densiti
cellswel
eagl
minimum
essenti
medium
emem
contain
fetal
bovin
serum
fb
incub
overnight
infect
mous
sera
serial
twofold
dilut
emem
contain
fb
heatinactiv
min
volum
pfu
human
wt
prepar
emem
contain
fb
combin
dilut
serum
sampl
incub
mixtur
subsequ
ad
cell
incub
h
incub
medium
replac
emem
contain
fb
cell
incub
neg
well
without
antiserum
exhibit
cytopath
effect
neutral
antibodi
titer
defin
reciproc
maximum
antiserum
dilut
allow
cell
remain
viabl
rel
control
serum
mucos
antibodi
concentr
among
differ
group
differ
time
point
compar
use
lsd
test
anovamanova
analysi
variancemultivari
analysi
varianc
statistica
softwar
statsoft
tulsa
ok
usa
compar
group
pvalu
consid
signific
signific
respect
